Healthcare provider profile · identity verified

Anna F Cosyleon, MD

Internal Medicine · CENTENNIAL, CO · NPI 1659401404

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	765	237
Levothyroxine Sodium	Levothyroxine Sodium	725	207
Lisinopril	Lisinopril	431	134
Omeprazole	Omeprazole	382	144
Simvastatin	Simvastatin	380	113
Losartan Potassium	Losartan Potassium	372	119
Amlodipine Besylate	Amlodipine Besylate	371	111
Rosuvastatin Calcium	Rosuvastatin Calcium	329	100
Alendronate Sodium	Alendronate Sodium	308	100
Tramadol Hcl	Tramadol Hcl	219	56
Pradaxa	Dabigatran Etexilate Mesylate	197	66
Gabapentin	Gabapentin	196	75
Pantoprazole Sodium	Pantoprazole Sodium	163	55
Sertraline Hcl	Sertraline Hcl	153	48
Hydrochlorothiazide	Hydrochlorothiazide	150	50
Duloxetine Hcl	Duloxetine Hcl	149	50
Albuterol Sulfate Hfa	Albuterol Sulfate	145	87
Mirtazapine	Mirtazapine	141	56
Fluoxetine Hcl	Fluoxetine Hcl	134	48
Jardiance	Empagliflozin	132	43
Trazodone Hcl	Trazodone Hcl	131	52
Metformin Hcl	Metformin Hcl	130	45
Atenolol	Atenolol	127	39
Metoprolol Tartrate	Metoprolol Tartrate	121	40
Estradiol	Estradiol	120	68
Meloxicam	Meloxicam	113	45
Metoprolol Succinate	Metoprolol Succinate	113	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	106	28
Metformin Hcl Er	Metformin Hcl	102	36
Glipizide	Glipizide	96	33
Tamsulosin Hcl	Tamsulosin Hcl	89	37
Acyclovir	Acyclovir	88	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	88	17
Spironolactone	Spironolactone	88	26
Escitalopram Oxalate	Escitalopram Oxalate	86	31
Potassium Chloride	Potassium Chloride	82	27
Arexvy	Rsvpref3 Antigen/As01e/Pf	79	79
Oxycodone Hcl	Oxycodone Hcl	79	22
Allopurinol	Allopurinol	78	22
Venlafaxine Hcl Er	Venlafaxine Hcl	78	26
Furosemide	Furosemide	76	33
Wixela Inhub	Fluticasone Propion/Salmeterol	74	29
Carvedilol	Carvedilol	73	24
Fluticasone Propionate	Fluticasone Propionate	70	29
Warfarin Sodium	Warfarin Sodium	65	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	18
Doxazosin Mesylate	Doxazosin Mesylate	61	17
Ozempic	Semaglutide	61	12
Propranolol Hcl	Propranolol Hcl	61	21
Eliquis	Apixaban	59	13
Bupropion Xl	Bupropion Hcl	57	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	55	16
Citalopram Hbr	Citalopram Hydrobromide	51	15
Famotidine	Famotidine	51	21
Triamcinolone Acetonide	Triamcinolone Acetonide	50	29
Breyna	Budesonide/Formoterol Fumarate	47	23
Ipratropium Bromide	Ipratropium Bromide	47	15
Finasteride	Finasteride	44	14
Clopidogrel	Clopidogrel Bisulfate	43	14
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	42	42
Alvesco	Ciclesonide	42	15
Clonazepam	Clonazepam	42	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	42	34
Sumatriptan Succinate	Sumatriptan Succinate	41	12
Cefuroxime	Cefuroxime Axetil	39	33
Cephalexin	Cephalexin	38	13
Shingrix	Varicella-Zoster Ge/As01b/Pf	37	36
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	36	15
Lorazepam	Lorazepam	34	20
Humulin N	Insulin Nph Human Isophane	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Spiriva Respimat	Tiotropium Bromide	30	16
Ezetimibe	Ezetimibe	28	13
Azelastine Hcl	Azelastine Hcl	26	11
Clobetasol Propionate	Clobetasol Propionate	26	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	24
Donepezil Hcl	Donepezil Hcl	25	suppressed
Azithromycin	Azithromycin	24	17
Risedronate Sodium	Risedronate Sodium	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Trospium Chloride	Trospium Chloride	23	suppressed
Prednisone	Prednisone	22	17
Colchicine	Colchicine	21	suppressed
Nitroglycerin	Nitroglycerin	21	12
Topiramate	Topiramate	21	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	20	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	11
Lamotrigine	Lamotrigine	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Retin-A	Tretinoin	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	12
Hydrocortisone	Hydrocortisone	19	13
Ondansetron Odt	Ondansetron	19	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Fluconazole	Fluconazole	17	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Montelukast Sodium	Montelukast Sodium	15	suppressed
Nystatin	Nystatin	15	11
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Humulin R	Insulin Regular, Human	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Lithium Carbonate	Lithium Carbonate	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Naloxone Hcl	Naloxone Hcl	12	12
Oxazepam	Oxazepam	12	suppressed
Striverdi Respimat	Olodaterol Hcl	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error